Journal of Antimicrobial Chemotherapy (2002) 50, 261-264
© 2002 The British Society for Antimicrobial Chemotherapy
Distribution of ß-lactamases in Acinetobacter baumannii clinical isolates and the effect of Syn 2190 (AmpC inhibitor) on the MICs of different ß-lactam antibiotics
Servei de Microbiologia, Institut Clínic Infeccions i Immunologia (ICII), Hospital Clínic-IDIBAPS, University of Barcelona, Villarroel 170, 08036 Barcelona, Spain
Received 19 September 2001; returned 28 December 2001; revised 28 February 2002; accepted 21 April 2002
The distribution of ß-lactamases in a group of 20 epidemiologically well defined Acinetobacter baumannii clinical isolates and the in vitro activity of Syn 2190, a novel ß-lactamase AmpC inhibitor, were determined. Twenty-five per cent of the strains carried and expressed a TEM-type ß-lactamase, whereas 35% had an OXA-type ß-lactamase. In nine out of 11 (82%) ceftazidime-resistant and four out of 13 (30.7%) cefepime-resistant strains, the MIC of these ß-lactam antibiotics decreased when determined in the presence of Syn 2190. Thus, our results suggest that in a high percentage of A. baumannii clinical isolates the increased production of AmpC, in combination or not with other resistance mechanisms, contributes to the resistance pattern in A. baumannii to ß-lactams.
* Corresponding author. Tel: +34-93-2275522; Fax: +34-93-2275454; E-mail: vila{at}medicina.ub.es
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
S. Bratu, D. Landman, D. A. Martin, C. Georgescu, and J. Quale Correlation of Antimicrobial Resistance with {beta}-Lactamases, the OmpA-Like Porin, and Efflux Pumps in Clinical Isolates of Acinetobacter baumannii Endemic to New York City Antimicrob. Agents Chemother., September 1, 2008; 52(9): 2999 - 3005. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Y. Peleg, H. Seifert, and D. L. Paterson Acinetobacter baumannii: Emergence of a Successful Pathogen Clin. Microbiol. Rev., July 1, 2008; 21(3): 538 - 582. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Ribera, F. Fernandez-Cuenca, A. Beceiro, G. Bou, L. Martinez-Martinez, A. Pascual, J. M. Cisneros, J. Rodriguez-Bano, J. Pachon, and J. Vila Antimicrobial Susceptibility and Mechanisms of Resistance to Quinolones and {beta}-Lactams in Acinetobacter Genospecies 3 Antimicrob. Agents Chemother., April 1, 2004; 48(4): 1430 - 1432. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Corvec, N. Caroff, E. Espaze, C. Giraudeau, H. Drugeon, and A. Reynaud AmpC cephalosporinase hyperproduction in Acinetobacter baumannii clinical strains J. Antimicrob. Chemother., October 1, 2003; 52(4): 629 - 635. [Abstract] [Full Text] [PDF] |
||||


